Case Studies

Case study
Enhancing Clinical Trial Site Risk Management with Real-Time AI-Enabled Oversight
Case study
Enhancing Clinical Trial Site Risk Management with Real-Time AI-Enabled Oversight
Case study
Optimize Salesforce Performance with GDPR-Compliant OwnBackup for Pharma’s Chronic Disease Division
Case study
Optimize Salesforce Performance with GDPR-Compliant OwnBackup for Pharma’s Chronic Disease Division
Case study
SciComm QR Code Portal: Secure & Scalable Document Distribution
Case study
SciComm QR Code Portal: Secure & Scalable Document Distribution
Case study
Ensuring Compliance: E-Signature with Immutable Audit Trail for Gene Therapy Workflow
Case study
Ensuring Compliance: E-Signature with Immutable Audit Trail for Gene Therapy Workflow

Events

20
Jun
2025

Pharma CXO Roundtable 2025

Advancing Life Sciences Business Process Innovation Using Autonomous Agentic Al

18
May
2025

PMSA 2025 Annual Conference

Revolutionizing Pharma Commercialization with Agilisium's AI Agents

2
Apr
2025

Bio-IT World 2025

Supercharge Life Sciences Innovation Using AI Agents

10
Mar
2025

Pharma SOS Annual Conference 2025

Revolutionizing Pharma Commercialization with AI Agents

White Papers

Trust by Design: Enabling Compliant & Resilient Data Operations in Salesforce

Digital transformation has made Salesforce the backbone of enterprise operations. But for regulated industries, the stakes are higher, data integrity, recoverability, and compliance aren’t optional, they’re mission critical. From 21 CFR Part 11 to HIPAA, GDPR, and GxP, the challenge isn’t just securing data, it’s proving compliance every day while still moving fast.

Fixing What Automation Missed: How Agentic AI Resolves Innovation and Automation Debt in Life Sciences

Life sciences organizations invested heavily in RPA, workflows, and now GenAI. But here’s the uncomfortable truth: automation alone has hit a wall. It streamlined tasks but left behind “innovation debt” and “automation debt”—siloed systems, stalled pilots, and slow decision cycles.

Beyond the Big Bet: Strategic AI Investments for a Smarter Pharma Future

AI is no longer an experimental pursuit in pharma, it’s a decisive driver of competitive advantage. In this exclusive Industry Briefing, Agilisium explores how pharmaceutical organizations are moving beyond big, one-time AI bets to adopt modular, ROI-focused strategies that unlock faster discovery, optimized trials, and measurable impact across the value chain. This briefing dives deep into how autonomous Agentic AI, outcome-based contracting, and domain-specific AI Centers of Excellence are driving a new era of agility, innovation, and strategic value.